C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/04 (2006.01) A61K 31/497 (2006.01) A61P 31/12 (2006.01) A61P 37/00 (2006.01) C07D 403/14 (2006.01) C07D 413/14 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2545425
A compound of general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating kinase-associated disease states using the compound of formula (I) is also described.
L'invention concerne un composé correspondant à la formule générale (I) ou ses promédicaments, sels, hydrates, solvates, formes cristallines ou diastéréomères pharmaceutiquement acceptables. Elle concerne aussi un procédé correspondant à un procédé pour traiter des états pathologiques associés aux kinases au moyen du composé correspondant à la formule (I).
Bu Xianyong
Burns Christopher John
Wilks Andrew Frederick
Cytopia Research Pty Ltd
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Ym Biosciences Australia Pty Ltd
LandOfFree
Azole-based kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azole-based kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azole-based kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1763190